{"_links":{"self":[{"href":"/project/GID-HST10044"}]},"_embedded":{"nice.indev:provisional-schedule-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:provisional-schedule":{"_links":{"self":[{}]},"ETag":null,"Column1":"Expected publication","Column2":"25 January 2023","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false}},"ETag":null},"nice.indev:timeline-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:timeline":[{"_links":{"self":[{}]},"ETag":null,"Column1":"08 September 2022","Column2":"Committee meeting","AdditionalInfoLabel":"Meeting number","AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"10 January 2022","Column2":"Invitation to participate","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"17 November 2021 - 15 December 2021","Column2":"Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"13 May 2021","Column2":"NICE, NHS England and NHS Improvement and PTC Therapeutics (the Company) have reached an agreement that will extend the Managed Access Agreement (MAA) for Translarna (ataluren) for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene. This agreement extends the MAA, that was originally scheduled to end in July 2021, to January 2023. This will enable PTC Therapeutics to access more complete data in preparation for their resubmission to NICE and the re-evaluation of ataluren before the end of the MAA, the outcome of which will determine how ataluren will be commissioned in the long term.","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"09 April 2021","Column2":"The Managed Access Agreement (MAA) for ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene is scheduled to end in July 2021. NICE, NHS England and NHS Improvement and PTC Therapeutics (the Company) are exploring options to extend the MAA to account for the new timeline for the NICE re-evaluation, which was paused as part of NICE’s COVID-19 workplan prioritisation framework. Discussions are continuing and an update will be issued as soon as the outcome is known.","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"06 April 2020","Column2":"In progress. Topic is in progress","AdditionalInfoLabel":"Link text","AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"06 April 2020","Column2":"Topic update: this evaluation has not been defined as therapeutically critical (please follow the link titled rapid guidelines and evidence summaries within the yellow banner at the top of the page for information on recent changes to the way we work). The appraisal will therefore be paused. At this stage, we are unable to provide alternative timelines as to when the appraisal may be re-started but we will provide updates as and when this information becomes clear. ","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false}]},"ETag":null},"nice.indev:process-homepage":{"_links":{"self":[{"href":"https://www.nice.org.uk/process/pmg20/chapter/introduction"},{}]},"ETag":null,"Description":"For further information on our processes and methods, please see our","LinkText":"CHTE processes and methods manual default"},"nice.indev:project-team-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:project-team":{"_links":{"self":[{}]},"ETag":null,"Column1":"Project lead","Column2":"Gavin Kenny"}},"ETag":null},"nice.indev:email-enquiry-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:email-enquiry":{"_links":{"self":[{}]},"ETag":null,"Item":"hst@nice.org.uk"}},"ETag":null},"nice.indev:consultee-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:consultee":[{"_links":{"self":[{}]},"ETag":null,"Column1":"Companies sponsors","Column2":"PTC Therapeutics (ataluren)"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Others","Column2":"•\tDepartment of Health"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Others","Column2":"•\tNational Commissioning Group for Rare Neuromuscular Disorders"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Others","Column2":"•\tNHS England"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Others","Column2":"•\tMRC Centre for Neuromuscular Diseases "},{"_links":{"self":[{}]},"ETag":null,"Column1":"Others","Column2":"•\tQueen Square Centre for Neuromuscular Diseases UCL"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Others","Column2":"•\tGreat Ormond Street Hospital "},{"_links":{"self":[{}]},"ETag":null,"Column1":"Others","Column2":"•\tCardiff and Vale University Health Board"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Others","Column2":"•\tAbertawe Bro Morgannwg University Health Board"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tAction Duchenne"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tAction for Sick Children"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tAlex’s Wish"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tArthritis & Musculoskeletal Alliance "},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tBlack Health Agency"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tChildren’s Society"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tContact"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tDisability Rights UK"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tDMD Pathfinders"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tDuchenne Family Support Group"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tDuchenne UK"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tFindacure"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tGene People"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tGenetic Alliance UK"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tHarrison’s Fund"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tJoining Jack"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tMuscular Dystrophy UK"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tSouth Asian Health Foundation"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tSpecialised Healthcare Alliance"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"•\tTogether for Short Lives"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tAssociation of Anaesthetists"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tAssociation of Genetic Nurses & Counsellors"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tAssociation of Respiratory Nurses"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tAssociation of Surgeons of Great Britain and Ireland"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tBritish Dietetic Association"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tBritish Institute of Musculoskeletal Medicine"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tBritish Orthopaedic Association"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tBritish Paediatric Neurology Association "},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tBritish Paediatric Respiratory Society"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tBritish Society for Genetic Medicine"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tBritish Society of Rehabilitation Medicine"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tBritish Thoracic Society"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tChartered Society for Physiotherapy"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tPhysiotherapy Pain Association"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tPrimary Care Respiratory Society"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tRoyal College of Anaesthetists"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tRoyal College of General Practitioners"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tRoyal College of Nursing"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tRoyal College of Paediatrics and Child Health"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tRoyal College of Pathologists"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tRoyal College of Physicians "},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tRoyal College of Surgeons"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tRoyal Pharmaceutical Society"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tRoyal Society of Medicine "},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tUK Clinical Pharmacy Association"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"•\tUK Genetic Testing Network"}]},"ETag":null},"nice.indev:commentator-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:commentator":[{"_links":{"self":[{}]},"ETag":null,"Column1":"Associated public health groups","Column2":"•\tPublic Health Wales"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Associated public health groups","Column2":"•\tUK Health security Agency"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Comparator companies","Column2":"None"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tAll Wales Therapeutics and Toxicology Centre"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tAllied Health Professionals Federation"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tBoard of Community Health Councils in Wales"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tBritish National Formulary"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tCare Quality Commission"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tDepartment of Health, Social Services and Public Safety for Northern Ireland"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tHealthcare Improvement Scotland"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tMedicines and Healthcare products Regulatory Agency "},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tNational Association of Primary Care"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tNational Pharmacy Association"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tNHS Alliance"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tNHS Commercial Medicines Unit"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tNHS Confederation"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tScottish Medicines Consortium"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tWelsh Government"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"•\tWelsh Health Specialised Services Committee"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Relevant research groups","Column2":"•\tBritish Myology Society"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Relevant research groups","Column2":"•\tCochrane Cystic Fibrosis and Genetic Disorders Group"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Relevant research groups","Column2":"•\tCochrane Musculoskeletal Group"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Relevant research groups","Column2":"•\tDuchenne Research Fund"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Relevant research groups","Column2":"•\tJohn Walton Centre for Muscular Dystrophy Research (Newcastle University)"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Relevant research groups","Column2":"•\tMRC Centre for Neuromuscular Diseases"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Relevant research groups","Column2":"•\tMRC Clinical Trials Unit"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Relevant research groups","Column2":"•\tNorth Star Clinical Network"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Relevant research groups","Column2":"•\tNational Institute for Health Research"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Relevant research groups","Column2":"•\tTREAT-NMD"}]},"ETag":null},"nice.indev:panel-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:panel":[{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource-list":{"_links":{"self":[{}]},"ETag":null,"HasResources":false}},"ETag":null,"Title":"Committee meetings","PanelType":"History","LegacyPanel":false,"OriginalReference":null,"UpdateReference":null,"ShowPanel":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource":[{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10044/documents/final-scope"}]},"ETag":null,"Id":"ea8557b9-0903-420d-8eac-fe1942db962f","MimeType":"application/pdf","FileName":"ID1642 ataluren for DMD (nonsense mutation) final scope to PM for ITP [noACIC] .pdf","Length":193267,"Hash":"B3855F5FD2627AA75F0E3633711D3BC90676CC2C","Name":"default","Reference":"GID-HST10044","ResourceTitleId":"final-scope","ConsultationDocumentId":0}},"ETag":null,"Title":"Final scope","Level":1,"PublishedDate":"2022-01-10T00:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10044/documents/scope-consultation-comments-and-responses"}]},"ETag":null,"Id":"ea61e5ed-5cc4-4767-8ded-ccd613e63797","MimeType":"application/pdf","FileName":"ID1642 ataluren for DMD consultation comments response table to PM for ITP [noACiC] .pdf","Length":251066,"Hash":"19822C74A2852B4079C592BA58794C9619CA01C8","Name":"default","Reference":"GID-HST10044","ResourceTitleId":"scope-consultation-comments-and-responses","ConsultationDocumentId":0}},"ETag":null,"Title":"NICE's response to comments on the draft scope and provisional stakeholder list","Level":1,"PublishedDate":"2022-01-10T00:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10044/documents/equality-impact-assessment-scoping"}]},"ETag":null,"Id":"ad9b3c7e-1d0e-4ee7-85ce-2c102600243f","MimeType":"application/pdf","FileName":"ID1642 ataluren for DMD EIA form scoping to PM for ITP [noACiC] .pdf","Length":128063,"Hash":"44B73841110E8790FFCB31FBA91A5FB6ABC1FA1C","Name":"default","Reference":"GID-HST10044","ResourceTitleId":"equality-impact-assessment-scoping","ConsultationDocumentId":0}},"ETag":null,"Title":"Equality impact assessment (Scoping)","Level":1,"PublishedDate":"2022-01-10T00:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10044/documents/final-matrix-2"}]},"ETag":null,"Id":"c90c21f3-cac7-46c7-8d7b-b4c22cd06924","MimeType":"application/pdf","FileName":"ID1642 ataluren final matrix for ITP [noACIC].pdf","Length":197827,"Hash":"B4F0A80037D9469503F1E1E72508CB82F7E4ACBE","Name":"default","Reference":"GID-HST10044","ResourceTitleId":"final-matrix-2","ConsultationDocumentId":0}},"ETag":null,"Title":"Final stakeholder list","Level":1,"PublishedDate":"2022-01-10T00:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false}]},"ETag":null,"HasResources":true}},"ETag":null,"Title":"Invitation to participate","PanelType":"History","LegacyPanel":false,"OriginalReference":null,"UpdateReference":null,"ShowPanel":true},{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource":[{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10044/documents/html-content"}]},"ETag":null,"Id":"fcda823f-f43b-4407-a7c3-955f05b8f022","MimeType":"text/html","FileName":"HtmlContent","Length":0,"Hash":"0631457264FF7F8D5FB1EDC2C0211992A67C73E6","Name":"default","Reference":"GID-HST10044","ResourceTitleId":"html-content","ConsultationDocumentId":0}},"ETag":null,"Title":"Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators","Level":1,"PublishedDate":"2021-11-18T09:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":1541,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10044/documents/draft-scope-post-referral"}]},"ETag":null,"Id":"da8dbb67-963d-49f7-8ebf-d46888e15372","MimeType":"application/pdf","FileName":"Appendix B ID1642 ataluren draft scope to for consultation [noACIC].pdf","Length":197264,"Hash":"E746DB8016D8560136C6A2ADCBAF4C58709CFBCE","Name":"default","Reference":"GID-HST10044","ResourceTitleId":"draft-scope-post-referral","ConsultationDocumentId":0}},"ETag":null,"Title":"Draft scope post referral","Level":1,"PublishedDate":"2021-11-17T00:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":1541,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10044/documents/draft-matrix-post-referral"}]},"ETag":null,"Id":"05bc7139-f778-4623-9036-6d88be87a4a7","MimeType":"application/pdf","FileName":"Appendix C ID1642 ataluren provisional stakeholder list for consultation [noACIC].pdf","Length":196116,"Hash":"C018528430573BF3326D7548B03229B6DA4FCB23","Name":"default","Reference":"GID-HST10044","ResourceTitleId":"draft-matrix-post-referral","ConsultationDocumentId":0}},"ETag":null,"Title":"Draft matrix post referral","Level":1,"PublishedDate":"2021-12-15T00:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":1541,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false}]},"ETag":null,"HasResources":true}},"ETag":null,"Title":"Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators","PanelType":"History","LegacyPanel":false,"OriginalReference":null,"UpdateReference":null,"ShowPanel":true}]},"ETag":null}},"ETag":"01000000-0000-0001-0000-000000000A39","Summary":null,"Description":null,"ReferralDate":null,"SuspendDiscontinuedReason":null,"SuspendDiscontinuedUrl":null,"SuspendDiscontinuedUrlText":null,"LegacyModel":false,"ProductReference":null,"EvidenceAssessmentGroup":"Warwick Evidence, Warwick Medical School, University of Warwick","Reference":"GID-HST10044","ProjectType":"HST","TechnologyType":null,"ProductTypeName":"Highly specialised technology","Process":"HST","Title":"Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene (review of HST3) ID1642","Status":"InProgress","ProjectGroup":"Guidance","PublishedDate":"2023-01-25T00:00:00","LastModifiedDate":"2022-01-11T11:20:38.4999065","FirstGoLiveDate":"2020-04-06T12:53:56.517777","CreatedDate":"2020-04-06T12:51:54.2677849","DevelopedAs":null,"RelevantTo":null,"IdNumber":"1642","AreasOfInterestList":[],"TopicSelectionDecision":"Selected","TopicSelectionReason":null,"TopicSelectionDecisionDate":null,"TopicSelectionFurtherInfo":null,"IndicatorSubTypes":[]}